BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3107495)

  • 1. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
    Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
    Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
    Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcome of hypertrophic and obstructive myocardiopathies treated with high doses of propranolol].
    Bourmayan C; Dussaule JC; Artigou JY; Fournier C; Fernandez F; Desnos M; Gerbaux A; Gay J
    Arch Mal Coeur Vaiss; 1985 Sep; 78(9):1409-16. PubMed ID: 3936444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective response to propranolol or verapamil in ischemia on effort.
    Levantesi D; Marraccini P; Michelassi C; Dalle Vacche M; L'Abbate A
    Can J Cardiol; 1989 Sep; 5(6):299-304. PubMed ID: 2676121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Verapamil versus propranolol in stable effort angina. Randomized, crossed, double-blind study].
    Lesbre JP; Lalau JD; Jaubourg ML; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1988 Apr; 37(4):205-10. PubMed ID: 3285763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative medical treatment of hypertrophic myocardiopathies].
    Kaltenbach M; Hopf R
    Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of medical and surgical therapy of hypertrophic obstructive cardiomyopathy (author's transl)].
    Lösse B; Kuhn H; Krönert H; Rafflenbeul D; Kirschner P; Schulte HD; Loogen F
    Z Kardiol; 1980 Jul; 69(7):470-7. PubMed ID: 7192456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 17. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
    Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial biopsy in patients with hypertrophic cardiomyopathy: correlations between morphologic and clinical parameters and development of myocardial hypertrophy under medical therapy.
    Kunkel B; Schneider M; Eisenmenger A; Bergmann B; Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():33-8. PubMed ID: 2963449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.